Get the Stockscreener App
4.43
5.34%
-0.25
After Hours:
4.47
0.04
+0.90%
Trisalus Life Sciences Inc stock is traded at $4.43, with a volume of 117.30K.
It is down -5.34% in the last 24 hours and up +21.37% over the past month.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
See More
Previous Close:
$4.68
Open:
$4.64
24h Volume:
117.30K
Relative Volume:
1.12
Market Cap:
$220.91M
Revenue:
$15.33M
Net Income/Loss:
$-40.19M
P/E Ratio:
-2.5283
EPS:
-1.7522
Net Cash Flow:
-
1W Performance:
-11.22%
1M Performance:
+21.37%
6M Performance:
-16.42%
1Y Performance:
-13.81%
1-Day Range:
$4.41
$4.715
1-Week Range:
$4.41
$5.10
52-Week Range:
$3.42
$5.88
Trisalus Life Sciences Inc Stock (TLSI) Company Profile
Name
Trisalus Life Sciences Inc
Sector
Industry
Phone
415 336 8917
Address
6272 WEST 91ST AVENUE, WESTMINSTER
Compare TLSI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TLSI
Trisalus Life Sciences Inc
|
4.43 | 235.87M | 15.33M | -40.19M | 0 | -1.7522 |
|
ABT
Abbott Laboratories
|
133.73 | 225.15B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.71 | 155.92B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
383.34 | 146.41B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
94.03 | 118.42B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
77.57 | 45.96B | 5.69B | 1.41B | 577.90M | 6.95 |
Trisalus Life Sciences Inc Stock (TLSI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-13-25 | Initiated | Lake Street | Buy |
| Dec-17-24 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-11-24 | Initiated | ROTH MKM | Buy |
| Oct-25-24 | Initiated | Northland Capital | Outperform |
| Sep-16-24 | Initiated | Oppenheimer | Outperform |
| May-30-24 | Initiated | Canaccord Genuity | Buy |
View All
Trisalus Life Sciences Inc Stock (TLSI) Latest News
Predicting TriSalus Life Sciences Inc. trend using moving averagesProfit Target & Intraday High Probability Setup Alerts - Newser
Detecting price anomalies in TriSalus Life Sciences Inc. Equity Warrant with AI2025 Top Decliners & Short-Term Swing Trade Alerts - Newser
What does recent volatility data suggest for TriSalus Life Sciences Inc. Equity WarrantWeekly Stock Analysis & Risk Managed Investment Strategies - Newser
Using AI based signals to follow TriSalus Life Sciences Inc.2025 Technical Patterns & Low Drawdown Investment Ideas - Newser
Is TriSalus Life Sciences Inc. reversing from oversold territoryEarnings Overview Report & Real-Time Buy Zone Alerts - Newser
TriSalus Life Sciences Inc. Equity Warrant stock trend forecastWeekly Risk Report & AI Forecast Swing Trade Picks - Newser
What does recent volatility data suggest for TriSalus Life Sciences Inc.Sell Signal & Safe Entry Momentum Tips - Newser
Short interest data insights for TriSalus Life Sciences Inc.Market Performance Report & Community Shared Stock Ideas - Newser
Key metrics from TriSalus Life Sciences Inc.’s quarterly dataWeekly Loss Report & Reliable Entry Point Trade Alerts - Newser
Real time breakdown of TriSalus Life Sciences Inc. stock performanceJuly 2025 Catalysts & Reliable Entry Point Trade Alerts - Newser
Using Python tools to backtest TriSalus Life Sciences Inc. Equity Warrant strategiesJuly 2025 Retail & Daily Stock Trend Reports - Newser
Will TriSalus Life Sciences Inc. Equity Warrant benefit from macro trendsJuly 2025 Breakouts & Weekly Watchlist of Top Performers - Newser
Earnings visualization tools for TriSalus Life Sciences Inc. Equity WarrantTrade Exit Summary & Technical Pattern Based Buy Signals - Newser
Key metrics from TriSalus Life Sciences Inc. Equity Warrant’s quarterly dataMarket Risk Report & Safe Entry Momentum Tips - Newser
Market reaction to TriSalus Life Sciences Inc. Equity Warrant’s recent newsWeekly Profit Recap & Verified Trade Idea Suggestions - Newser
Using data tools to time your TriSalus Life Sciences Inc. exitForecast Cut & Fast Entry High Yield Tips - Newser
Developing predictive dashboards with TriSalus Life Sciences Inc. Equity Warrant data2025 Price Action Summary & Low Risk Entry Point Tips - Newser
How to integrate TriSalus Life Sciences Inc. into portfolio analysis toolsJuly 2025 Fed Impact & Consistent Profit Alerts - Newser
Can TriSalus Life Sciences Inc. rally from current levelsPortfolio Update Summary & Proven Capital Preservation Methods - Newser
Volatility clustering patterns for TriSalus Life Sciences Inc. Equity Warrant2025 Growth vs Value & Reliable Breakout Forecasts - Newser
Advanced analytics toolkit walkthrough for TriSalus Life Sciences Inc.Analyst Upgrade & Daily Stock Trend Reports - Newser
Is TriSalus Life Sciences Inc. Equity Warrant stock ready for a breakoutPortfolio Risk Report & Safe Entry Trade Signal Reports - Newser
Exit strategy if you’re trapped in TriSalus Life Sciences Inc.Weekly Profit Summary & Consistent Return Investment Signals - Newser
Technical analysis overview for TriSalus Life Sciences Inc. stock - Newser
What the charts say about TriSalus Life Sciences Inc. todayEarnings Growth Summary & Verified Momentum Watchlists - Newser
How to recover losses in TriSalus Life Sciences Inc. stockJuly 2025 Intraday Action & Weekly Chart Analysis and Trade Guides - Newser
Comparing TriSalus Life Sciences Inc. Equity Warrant in custom built stock radarsWeekly Market Outlook & Weekly High Return Stock Forecasts - Newser
Does TriSalus Life Sciences Inc. Equity Warrant show high probability of reboundEarnings Risk Summary & Risk Controlled Swing Trade Alerts - Newser
Will earnings trigger a reversal in TriSalus Life Sciences Inc.2025 Key Highlights & Weekly Setup with ROI Potential - Newser
Published on: 2025-09-11 18:02:53 - Newser
How to track smart money flows in TriSalus Life Sciences Inc.Trade Risk Report & Low Drawdown Trading Techniques - Newser
heatmap analysis for trisalus life sciences inc. and competitorsTrade Volume Report & Weekly High Potential Stock Alerts - Newser
Price momentum metrics for TriSalus Life Sciences Inc. explainedJuly 2025 News Drivers & Daily Profit Maximizing Tips - Newser
Key resistance and support levels for TriSalus Life Sciences Inc.Quarterly Portfolio Summary & Community Consensus Trade Alerts - Newser
Is TriSalus Life Sciences Inc. trending in predictive chart modelsEarnings Risk Report & Community Driven Trade Alerts - Newser
Analyzing recovery setups for TriSalus Life Sciences Inc. Equity Warrant investors2025 Historical Comparison & Consistent Growth Stock Picks - Newser
Heatmap analysis for TriSalus Life Sciences Inc. and competitors2025 Price Targets & Long-Term Capital Growth Strategies - Newser
What to expect from TriSalus Life Sciences Inc. Equity Warrant in the next 30 daysJuly 2025 Final Week & Verified Momentum Stock Watchlist - Newser
How to build a dashboard for TriSalus Life Sciences Inc. Equity Warrant stock2025 Price Action Summary & Weekly High Return Forecasts - Newser
Risk adjusted return profile for TriSalus Life Sciences Inc. analyzedWeekly Market Summary & Safe Capital Allocation Plans - Newser
Analyzing net buyer seller activity in TriSalus Life Sciences Inc. Equity WarrantJobs Report & Free AI Powered Buy and Sell Recommendations - Newser
Trisalus Life Sciences Inc Stock (TLSI) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.14%
1.01%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):